title: MRX 115, an echocardiographic contrast agent, produces myocardial opacification after intravenous injection in primates: studies before and after occlusion of left anterior descending coronary artery.
authors.affiliation: Department of Medicine (Cardiology), Oregon Health Sciences University, Portland 97201, USA.
authors.forename: S E
authors.initials: SE
authors.lastname: Grauer
authors.forename: J
authors.initials: J
authors.lastname: Xu
authors.forename: G A
authors.initials: GA
authors.lastname: Pantely
authors.forename: S
authors.initials: S
authors.lastname: Ge
authors.forename: Z
authors.initials: Z
authors.lastname: Gong
authors.forename: T
authors.initials: T
authors.lastname: Shiota
authors.forename: X
authors.initials: X
authors.lastname: Zhou
authors.forename: D J
authors.initials: DJ
authors.lastname: Sahn
mesh_terms: D000818:Animals; D003287:Contrast Media / Q000008:administration & dosage; D003326:Coronary Circulation / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004452:Echocardiography; D005466:Fluorocarbons; D005740:Gases; D007275:Injections, Intravenous; D008051:Lipid Bilayers; D008253:Macaca mulatta; D009203:Myocardial Infarction / Q000000981:diagnostic imaging*
chemical_list: D003287:Contrast Media; D005466:Fluorocarbons; D005740:Gases; D008051:Lipid Bilayers; C042852:perflutren